New combo aims to shrink hard-to-treat pancreatic tumors
Disease control
Recruiting now
This early-phase trial tests a new drug called PTM-101 given alongside standard chemotherapy for people with pancreatic cancer that is either borderline resectable or locally advanced. The goal is to see if the combination is safe and can shrink tumors enough to allow surgery. Ab…
Phase: PHASE1 • Sponsor: PanTher Therapeutics • Aim: Disease control
Last updated May 04, 2026 16:24 UTC